Combined risk stratification with computerized tomography /echocardiography and biomarkers in patients with normotensive pulmonary embolism.

[1]  R. Yusen,et al.  Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism: systematic review and metaanalysis. , 2009, Chest.

[2]  Y. Lacasse,et al.  Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis , 2009, Thorax.

[3]  J. Alonso-Martínez,et al.  N-Terminal Pro-B-Type Natriuretic Peptide Predicts the Burden of Pulmonary Embolism , 2009, The American journal of the medical sciences.

[4]  Piotr Pruszczyk,et al.  Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .

[5]  L. Trinquart,et al.  Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. , 2008, European heart journal.

[6]  M. Olschewski,et al.  Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. , 2008, American journal of respiratory and critical care medicine.

[7]  H. Büller,et al.  Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. , 2007, International journal of cardiology.

[8]  Yuanhua Yang,et al.  Value of transthoracic echocardiography combined with cardiac troponin I in risk stratification in acute pulmonary thromboembolism. , 2007, Chinese medical journal.

[9]  S. Vanni,et al.  Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. , 2006, The American journal of cardiology.

[10]  Z. Bartoszewicz,et al.  Biomarker-based risk assessment model in acute pulmonary embolism. , 2005, European heart journal.

[11]  M. Olschewski,et al.  N-Terminal Pro-Brain Natriuretic Peptide or Troponin Testing Followed by Echocardiography for Risk Stratification of Acute Pulmonary Embolism , 2005, Circulation.

[12]  H. Buller,et al.  Prognostic value of echocardiography and spiral computed tomography in patients with pulmonary embolism , 2005, Current opinion in pulmonary medicine.

[13]  S. Solomon,et al.  Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. , 2005, The American journal of cardiology.

[14]  H. Putter,et al.  Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. , 2005, Radiology.

[15]  U. Schoepf,et al.  Right Ventricular Enlargement on Chest Computed Tomography: A Predictor of Early Death in Acute Pulmonary Embolism , 2004, Circulation.

[16]  Andrew D. Auerbach,et al.  Helical CT Pulmonary Angiography Predictors of In-Hospital Morbidity and Mortality in Patients With Acute Pulmonary Embolism , 2003, Journal of thoracic imaging.

[17]  O. Hess,et al.  Incremental prognostic value of troponin I and echocardiography in patients with acute pulmonary embolism. , 2003, European heart journal.

[18]  A. Torbicki,et al.  Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. , 2003, Chest.

[19]  S. Goldhaber,et al.  Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism , 2003, Circulation.

[20]  O. Hess,et al.  Low Pro-Brain Natriuretic Peptide Levels Predict Benign Clinical Outcome in Acute Pulmonary Embolism , 2003, Circulation.

[21]  Kenneth E Wood,et al.  Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. , 2002, Chest.

[22]  A. Buchwald,et al.  Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. , 2000, Journal of the American College of Cardiology.

[23]  P. Cecchini,et al.  Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. , 2000, Circulation.

[24]  Samuel Z Goldhaber,et al.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.

[25]  M Gent,et al.  Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism , 1998, Annals of Internal Medicine.

[26]  M. Olschewski,et al.  Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. , 1997, Journal of the American College of Cardiology.

[27]  J. Alpert,et al.  Mortality in patients treated for pulmonary embolism. , 1976, JAMA.

[28]  C. Hassager,et al.  Prognostic importance of quantitative echocardiographic evaluation in patients suspected of first non-massive pulmonary embolism. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[29]  W. Brady,et al.  Fibrinolytic therapy in pulmonary embolism: an evidence-based treatment algorithm. , 2009, The American journal of emergency medicine.

[30]  D. Hochstrasser,et al.  Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism. , 2008, Thrombosis research.